ANXA11 and Alzheimer disease: Our previous work (Khullar and Wang 2023, Khullar 2024) identifies ANXA11 as 1 of 36 AD-Covid risk candidate neuroinflammatory biomarker genes (Zhang et al. 2024) and assigns ANXA11 to a Control gene co-expression module in the Hippocampus brain region.